Reprai - About the company
Reprai is an unfunded company based in Netherlands, founded in 2024 by Ozhan Ozturk. It operates as an Online platform for pharmaceutical companies to reach and engage with healthcare professionals. Reprai has not raised any funding yet. The company has 146 active competitors, including 19 funded and 33 that have exited. Its top competitors include companies like ACTO, IntegriChain and Axtria.
Company Details
Online platform for pharmaceutical companies to reach and engage with healthcare professionals. It offers AI-powered technology optimizing communication with healthcare professionals, handle the complexities of promotional operations, and streamlines the workflow. It also offers segmentation tool that analyzes data in real-time to categorize audience and deliver targeted content..
- Website
- reprai.com
- Phone Number
- +1 **********
Key Metrics
Sign up to download Reprai's company profile
Reprai's funding and investors
Reprai has not raised any funding rounds yet.
Reprai's founders and board of directors
Founder? Claim ProfileThe founders of Reprai is Ozhan Ozturk.
Here are the details of Reprai's key team members:
- Ozhan Ozturk: Co-Founder of Reprai. Contact Info: 1 email address
View details of Reprai's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Reprai's Competitors and alternates
Top competitors of Reprai include ACTO, IntegriChain and Axtria. Here is the list of Top 10 competitors of Reprai, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of an AI and SaaS-based educational platform for the life science industry | $39.5M | 69/100 | ||
2nd | IntegriChain 2005, Philadelphia (United States), Acquired | Pharma commercialization solutions: data, consulting, and technology for market access | $2M | 65/100 | |
3rd | Axtria 2009, Berkeley Heights (United States), Series D | Provider of AI-powered data analytics and commercial solutions for life sciences | $199M | 63/100 | |
4th | IMS Health 1954, Danbury (United States), Acquired | Provider of SaaS and AI based market intelligence platform for healthcare and pharmaceutical companies | - | 60/100 | |
5th | Multiplier AI 2011, Hyderabad (India), Seed | Developer of an AI based pharma marketing platform for life sciences firm | $2.08M | 59/100 | |
6th | CompareNetworks 2000, San Francisco (United States), Acquired | B2B media and tech company empowering professionals with information and tools | $21.7M | 59/100 | |
7th | A technology-driven business services provider in healthcare | $46.7M | 56/100 | ||
8th | Digital data flow management services | - | 55/100 | ||
9th | CenterWatch 1994, Boston (United States), Acquired | Online platform for clinical trials information | - | - | 51/100 |
10th | SHYFT Analytics 2005, Waltham (United States), Acquired | Data Management and analytic solutions for life sciences | $61.5M | 50/100 | |
103rd | Reprai 2024, Netherlands, Unfunded | Online platform for pharmaceutical companies to reach and engage with healthcare professionals | - | - | 24/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Reprai's competitors? Click here to see the top ones
Reprai's Investments and acquisitions
Reprai has made no investments or acquisitions yet.
Reports related to Reprai
Here is the latest report on Reprai's sector:
Are you a Founder ?
FAQs about Reprai
Explore our recently published companies
- Versicherungsmakler Saarland - Berlin based, Unfunded company
- EuLaudo - Belo Horizonte based, 2020 founded, Unfunded company
- Red Sea Eco Solutions & Instruments - Chennai based, 2012 founded, Unfunded company
- Caspian.ai - San Francisco based, 2020 founded, Unfunded company
- Polymath - New York City based, 1996 founded, Unfunded company
- Recocent - Mumbai based, 2025 founded, Unfunded company
